Jonathan M Amiel
Affiliation: Columbia University
- Glutamate and anxiety disordersJonathan M Amiel
Columbia University Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA
Curr Psychiatry Rep 9:278-83. 2007....
- Addressing cardiometabolic risk during treatment with antipsychotic medicationsJonathan M Amiel
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA
Curr Opin Psychiatry 21:613-8. 2008..To raise awareness of and inform evidence-based practice regarding medical and behavioral interventions for antipsychotic medication-induced metabolic abnormalities...
- The medical home model: new opportunities for psychiatric services in the United StatesJonathan M Amiel
Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York Presbyterian Hospital, New York, USA
Curr Opin Psychiatry 24:562-8. 2011..This review highlights the development of the medical home model and a number of ways in which it has been adopted in psychiatric delivery systems...
- Open-label trial of riluzole in generalized anxiety disorderSanjay J Mathew
Department of Biological Psychiatry, New York State Psychiatric Institute, USA
Am J Psychiatry 162:2379-81. 2005..There is a need to identify novel pharmacotherapies for anxiety disorders. The authors examined the safety and efficacy of riluzole, an antiglutamatergic agent, in adult outpatients with generalized anxiety disorder...